CINECA IRIS Institutional Research Information System

MOGLIA, Cristina

MOGLIA, Cristina  

NEUROSCIENZE "RITA LEVI MONTALCINI"  

Mostra records
Risultati 1 - 20 di 170 (tempo di esecuzione: 0.04 secondi).
Titolo Data di pubblicazione Autore(i) File
18 F-FDG-PET correlates of cognitive impairment in ALS 2016 Canosa, Antonio; Pagani, Marco; Cistaro, Angelina; Montuschi, Anna; Iazzolino, Barbara; Fania, Piercarlo; Cammarosano, Stefania; Ilardi, Antonio; Moglia, Cristina; Calvo, Andrea; Chiò, Adriano
A Strange Loop: Effects of emotional facial expressions impaired recognition in ALS Patients and in their Caregivers. 2012 A. Montuschi; A. Lo Presti; C. Moglia; A. Calvo; M. Lo Russo; F. Casale; M. Tamietto; A. Chiò
A cluster of ALS Cases in Sardinia due to a founder mutation of the TARDBP gene 2011 Chio' A; Borghero G; Pugliatti M; Ticca A; Calvo A; Moglia C; brunetti M; Ossola I; Marrosu M; Murru MR; Floris G; Cannas A; Parish LD; Cossu p; Abramzon Y; Johnson JO; Arepalli S; Chong S; Hernandez DG; Traynor BJ; Restagno G
A de novo missense mutation of the FUS gene in a "true" sporadic ALS case 2011 Chiò A; Calvo A; Moglia C; Ossola I; Brunetti M; Sbaiz L; Lai SL; Abramzon Y; Traynor BJ; Restagno G
A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. 2014 A. Calvo;C. Moglia;A. Canosa;M. Brunetti;M. Barberis;B. J. Traynor;G. Carrara;C. Valentini;G. Restagno;A. Chiò
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 2014 A. Canosa;A. Calvo;C. Moglia;B. Iazzolino;M. Brunetti;G. Restagno;A. Cistaro;P. Fania;G. Carrara;M. C. Valentini;R. Tanel;A. Chiò
A longitudinal study on quality of life and depression in ALS patient-caregiver couples 2007 A. GAUTHIER; A. VIGNOLA; A. CALVO; E. CAVALLO; C. MOGLIA; L. SELLITTI; R. MUTANI; A. CHIO'
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 2015 A. Canosa;A. Calvo;C. Moglia;M. Barberis;M. Brunetti;S. Cammarosano;U. Manera;A. Ilardi;G. Restagno;A. Chiò
A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD 2011 Borghero G; Floris G; Cannas A; Marrosu MG; Murru MR; Costantino E; Parish LD; Pugliatti M; Ticca A; Traynor BJ; Calvo A; Cammarosano S; Moglia C; Cistaro A; Brunetti M; Restagno G; Chiò A
A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results 2009 Moglia C; Calvo A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Corbo M; Mancardi GL; Tonali PA; Mutani R; Tarella C; Chio' A
A pilot trial of G-CSF in amyotrophic lateral sclerosis 2008 Chio' A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Moglia C; Mancardi GL; Tonali P; Calvo A; Mutani R; Corbo M; Scime’ R; D’Onofrio G; Petrini M; Melazzini M. Gualandi F; Tarella C
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 2020 Cabras, Sara; Calvo, Andrea; Moglia, Cristina; Chiò, Adriano; Canosa, Antonio
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 2011 Chiò A; Canosa A; Gallo S; Cammarosano S; Moglia C; Fuda G; Calvo A; Mora G; For the PARALS group
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 2011 Chio' A; Mora G; Moglia C; Fuda G; Canosa A; Gallo S; Cammarosano S; Ilardi A; Calvo A
ALS phenotype is influenced by age, sex, and genetics: A population-based study 2020 Chiò, Adriano; Moglia, Cristina; Canosa, Antonio; Manera, Umberto; D'Ovidio, Fabrizio; Vasta, Rosario; Grassano, Maurizio; Brunetti, Maura; Barberis, Marco; Corrado, Lucia; D'Alfonso, Sandra; Iazzolino, Barbara; Peotta, Laura; Sarnelli, Maria Francesca; Solara, Valentina; Zucchetti, Jean Pierre; De Marchi, Fabiola; Mazzini, Letizia; Mora, Gabriele; Calvo, Andrea
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations 2012 Chio' A; Restagno G; Brunetti M; Ossola I; Calvo A; Canosa A; Moglia C; Floris G; Tacconi P; Marrosu F; Marrosu MG; Murru MR; Majounie E; Renton AE; Abramzon Y; Pugliatti M; Sotgiu MA; Traynor BJ; Borghero G
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 2021 Giusiano S.; Peotta L.; Iazzolino B.; Mastro E.; Arcari M.; Palumbo F.; Torrieri M.C.; Bombaci A.; Grassano M.; Cabras S.; Di Pede F.; De Mattei F.; Matteoni E.; Solero L.; Daviddi M.; Salamone P.; Fuda G.; Manera U.; Canosa A.; Chio A.; Calvo A.; Moglia C.; Vasta R.
Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma 2010 A.Calvo; F.Benech; P.Ghiglione; M.Balma; C.Moglia; R.Mutani; A.Chio
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 2015 A. Canosa;A. Calvo;M. Barberis;M. Brunetti;G. Restagno;S. Cammarosano;A. Ilardi;M. C. Vigliani;A. Chiò;C. Moglia
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 2014 A. Chiò;A. Calvo;G. Bovio;A. Canosa;D. Bertuzzo;F. Galmozzi;P. Cugnasco;M. Clerico;S. De Mercanti;E. Bersano;S. Cammarosano;A. Ilardi;U. Manera;C. Moglia;R. Sideri;K. Marinou;E. Bottacchi;F. Pisano;R. Cantello;L. Mazzini;G. Mora; Piemonte;V. d. Register